- Vancouver Tech Journal
- Posts
- Bulletin: Despite domestic snubbing, AbCellera made nearly $200 million off of its COVID-19 treatment
Bulletin: Despite domestic snubbing, AbCellera made nearly $200 million off of its COVID-19 treatment
Plus, it generated a net profit of $119 million USD, up from a net loss of $2 million on $11.6 million in revenue.
Premium Content
Become a paying subscriber of Vancouver Tech Journal to get access to this page and other subscriber-only content.
What you get when you upgrade:
Already a subscriber?Sign In.Upgrade to view premium content.- 🔑 Exclusive content: In-depth stories that you won't find anywhere else
- 🎟️ First access to events we put on
- 🔒 The Morning Report, an email digest of need-to-know stories and deals
- 🗓️ Discounted and invitation-only events